I forgot to mention that a ROW deal/deals could also be included here. That sorts out ACADs lack of ROW distribution,
This structure would allow ACAD to mitigate and distribute the risks. Just like Lloyd’s Insureance.
And maybe add a significant amount that f upfront cash which ACAD could put towards financing this deal,
Ann: Neuren approaching key milestones in Q4 2019, page-114
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |